Prosthetic joint infection in solid organ transplant recipients: A retrospective case-control study

Transplant Infectious Disease

Volumn 14, Issue 4, 2012, Pages 380-386

  Vergidis, P ^a   Lesnick, T G ^a   Kremers, W K ^a   Razonable, R R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biofilm; Non tuberculous mycobacteria; Prosthetic joint infection; Solid organ transplantation

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLARITHROMYCIN; CLOFAZIMINE; CORTICOSTEROID; CYCLOSPORIN; ERTAPENEM; ETHAMBUTOL; LEVOFLOXACIN; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; TACROLIMUS; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAM POSITIVE BACTERIUM; HEART TRANSPLANTATION; HIP ARTHROPLASTY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; KNEE ARTHROPLASTY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORGAN TRANSPLANTATION; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; RETROSPECTIVE STUDY; SOLID ORGAN TRANSPLANTATION; STAPHYLOCOCCUS; STREPTOCOCCUS;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT; CASE-CONTROL STUDIES; FEMALE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HIP JOINT; HUMANS; JOINT PROSTHESIS; KNEE JOINT; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84865190709     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00708.x     Document Type: Article

References (24)

1. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23 (7): 984-991.
2. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 1984; 182: 117-126.
3. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27 (5): 1247-1254.
4. Aslam S, Reitman C, Darouiche RO. Risk factors for subsequent diagnosis of prosthetic joint infection. Infect Control Hosp Epidemiol 2010; 31 (3): 298-301.
5. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001; 392: 15-23.
6. Dowsey MM, Choong PF. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res 2008; 466 (1): 153-158.
7. Jamsen E, Nevalainen P, Kalliovalkama J, Moilanen T. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med 2010; 21 (3): 196-201.
8. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357 (25): 2601-2614.
9. van den Berg AP, Klompmaker IJ, Haagsma EB, et al. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin Transplant 1996; 10 (2): 224-231.
10. Landmann J, Renner N, Gachter A, Thiel G, Harder F. Cyclosporin A and osteonecrosis of the femoral head. J Bone Joint Surg Am 1987; 69 (8): 1226-1228.
11. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63 (7): 977-983.
12. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009; 361 (8): 787-794.
13. Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007; 45 (9): 1113-1119.
14. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Osmon DR. Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am J Orthop (Belle Mead NJ) 1998; 27 (3): 219-227.
15. Spinner RJ, Sexton DJ, Goldner RD, Levin LS. Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J Arthroplasty 1996; 11 (2): 217-222.
16. Cornelius L, Reddix R, Burchett C, Bond G, Fader R. Cluster of Mycobacterium fortuitum prosthetic joint infections. J Surg Orthop Adv 2007; 16 (4): 196-198.
17. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis 2007; 45 (6): 687-694.
18. Ojha AK, Baughn AD, Sambandan D, et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 2008; 69 (1): 164-174.
19. Williams MM, Yakrus MA, Arduino MJ, et al. Structural analysis of biofilm formation by rapidly and slowly growing nontuberculous mycobacteria. Appl Environ Microbiol 2009; 75 (7): 2091-2098.
20. Gupta A, Clauss H. Prosthetic joint infection with Mycobacterium avium complex in a solid organ transplant recipient. Transpl Infect Dis 2009; 11 (6): 537-540.
21. Isono SS, Woolson ST, Schurman DJ. Total joint arthroplasty for steroid-induced osteonecrosis in cardiac transplant patients. Clin Orthop Relat Res 1987; 217: 201-208.
22. McLaughlin JR, Tierney M, Harris WH. Mycobacterium avium intracellulare infection of hip arthroplasties in an AIDS patient. J Bone Joint Surg Br 1994; 76 (3): 498-499.
23. Dean PG, Lund WJ, Larson TS, et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004; 77 (10): 1555-1561.
24. Fortun J, Martin-Davila P, Pascual J, et al. Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis 2010; 12 (5): 397-405.